Preview Mode Links will not work in preview mode

Oct 31, 2022

Featuring perspectives from Dr Pasi Jänne, including the following topics:

  • Introduction: Journal Club with Pasi A Jänne, MD, PhD — Part 1 (0:00)
  • Case: An Asian man in his late 60s with adenocarcinoma of the lung and pleural effusion with EGFR amplification (PD-L1 20%) — Jennifer L Dallas, MD (12:33)
  • Case: A man...

Oct 28, 2022

Featuring perspectives from Dr Sagar Lonial, including the following topics:

  • Journal Club with Sagar Lonial, MD — Part 1 (0:00)
  • Case: A man in his late 50s with relapsed t(11;14) multiple myeloma (MM) 17 years after initial induction treatment and ASCT — Rajalaxmi McKenna, MD (16:45)
  • Case: A man in his mid 70s with...

Oct 27, 2022

Featuring an interview with Prof Axel Hauschild, including the following topics:

  • Pan-tumor approval of dabrafenib/trametinib; data with adjuvant targeted therapy for melanoma (0:00)
  • Emerging data with encorafenib/binimetinib for Stage II melanoma; switching from dabrafenib/trametinib...

Oct 27, 2022

Featuring a slide presentation and related discussion from Prof Axel Hauschild, including the following topics:

  • Emerging data with targeted agents for metastatic melanoma (0:00)
  • Current and future roles for immune checkpoint inhibitors in therapy for melanoma (11:13)
  • Comparing targeted agents and immune checkpoint...

Oct 26, 2022

Featuring perspectives from Drs Jeremy Abramson, Sonali Smith and Jason Westin, including the following topics:

  • Prologue (0:00)
  • First-line treatment (3:38)
  • Bispecific antibodies (34:41)
  • CAR T-cell therapy (48:21)

CME information and select publications